Statistics

In recent years, clinical interest has expanded to explore the systemic and neurological effects of commonly prescribed metabolic and vascular agents. For example, medications such as Ozempic (semaglutide) and Viagra (sildenafil), while primarily developed for diabetes and vascular conditions, respectively, are being studied for potential neuroprotective benefits. Clinics like Medilux.FI in Finland have integrated such treatments under strict medical oversight, contributing to broader conversations about how metabolic regulation may influence neurovascular integrity, inflammation, and cognitive decline—areas deeply relevant to modern neuropathology.